Three new Lycopodium alkaloids, obscurumines C-E (1-3), along with nine known compounds, were isolated from the club moss Lycopodium obscurum L. Structures of the new compounds were determined on the basis of their spectroscopic analysis and the relative configurations of 1 were established by X-ray crystallographic analysis. All the new isolates were tested for the acetylcholinesterase (AChE) inhibitory activity.
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Introduction
The Lycopodium alkaloids represent a large family of plant secondary metabolites obtained from the club moss belonging to Lycopodiaceae. 1, 2 Since the impressively diverse skeletons and interesting biological activities, these alkaloids continue to be of interest from a biogenetic and biological point of view and some of them have been challenging targets for total synthesis. [3] [4] [5] Lycopodium obscurum L., one of the club moss, has been used in China as a traditional folk medicine for the treatment of contusion, dysmenorrhea, quadriplegia, and arthritic pain. 6, 7 Previously phytochemical investigation indicated triterpenoids were the main compounds of this plant and only few Lycopodium alkaloids were isolated. [8] [9] [10] As part of an ongoing program aimed at discovering structurally interesting and bioactive Lycopodium alkaloids, 11, 12 three new Lycopodium alkaloids, obscurumines C-E (1-3), along with nine known compounds, were isolated from the whole herb of L. obscurum L. Herein, we report the isolation, structure elucidation, and acetylcholinesterase (AChE) inhibitory activity of the new isolates.
Results and Discussion
The alkaloidal extract of L. obscurum was separated by normal-phase silica gel, RP-18 silica gel, HPLC, and Sephadex LH-20 chromatography to afford three new Lycopodium alkaloids, obscurumines C-E (1-3), along with nine known compounds. The structures of known compounds, compared with literatures data, were identified as lycopodine, 13 anhydrolycodoline, 14 obscurinine, 9 obscurinine B, 8 lycoflexine, 15 acetyldihydrolycopodine, 16 (+)-acetylfawcettiine, 17 Ndemethyl-α-obscurine, 18 N-demethyl-β-obscurine. 19 Obscurumine C (1), colorless crystals, has a molecular formula C 16 indicated the connection of C-4/C-5/C-6. While, the connection of C-4/C-13/C-14 were derived from HMBC cross-peaks of H-4 and H-14 to C-13. Meanwhile, the HMBC correlations of H-1 with C-9 and C-13 established the connections of C-1, Figure 1 . Chemical structure of isolated compounds 1-3 *To whom correspondence should be addressed. E-mail: qinshizhao@mail.kib.ac.cn C-9, and C-13 through a nitrogen atom. The above analysis indicated 1 should be a lycopodine-type alkaloid with many similarities to that of anhydrolycodoline, 14 a known compound also isolated during the isolation. The obvious differences were that 1 possessed two more carbonyl groups one of which was connected to C-9 ( C 155.8) as deduced from the HMBC correlations of H-1 and H-11 with C-9. The other carbonyl group was speculated to attached at C-10 according to the 13 C chemical shift and confirmed by the HMBC correlations of H-11 to C-10. Thus, the gross structure of obscurumine C (1) was elucidated to be 1 possessing a lycopodine-type skeleton with a scarce two adjacent ketones unit.
The relative configuration of 1 was established by ROESY experiment. In the ROESY spectrum, the correlations of H-4 with H-6b and H-6a with H-15 were observed which indicated the α-orientation of H-4 and Me-16. Since the two adjacent ketone unit is scarce in Lycopodium alkaloid and to confirm the structure and the relative configuration, a X-ray crystallographic analysis of 1 ( Figure 2 ) was carried out which unambiguously certificated the structure and the relative configurations of compound 1.
Compound 2 was obtained as colorless oil. The HREIMS analysis gave an m/z at 261.1735 ([M + ]) (calc. 261.1729) that established the molecular formula C 16 H 23 NO 2 , corresponding to six degrees of unsaturation. The 13 C NMR spectrum displayed 16 carbon signals due to one methyl, eight methylene, four methine, and three quaternary carbons. Among them, one sp 3 quaternary carbon ( C 96.5) was ascribed to the carbon (C-13) which bearing both an oxygen atom and a nitrogen atom and one sp 2 quaternary carbons were attributable to the ketone group ( C 218.2). Partial structures a-c (C-1-C-4, C-6-C-8/C-15, and C-9-C-11) were deduced from Further detailed 2D NMR analysis suggested compound 2 was a fawcettimine-type alkaloid which was similar to that of fawcettimine. 20 The obvious difference was that 2 has one oxygened methine group rather than a methylene group in fawcettimine, which was connected to C-10 as deduced from the 1 H-1 H COSY ) groups. The 13 C NMR and DEPT spectra revealed the existence of seventeen carbons due to three quaternary carbons, six methine groups, six methylene groups, and two methyl groups. Detailed analysis of its 1D and 2D NMR data suggested that 3 was similar to that of epilobscurinol. 18 The only difference was that the double bond between C-3/C-4 in epi-lobscurinol was shift to C-2/C-3 as deduced from the 1 H-1 H COSY correlations of H-1/H-2/H-3/H-4 and confirmed by the HMBC correlations of H-2 with C-1 and C-4. In the ROESY spectrum, the correlations of H-4/H-11b and H-5/H-7 were observed which suggested the relative configuration of 3 was the same as epi-lobscurinol. So, the structure of 3 was deduced and shown in Figure 1 .
The new compounds obscurumine C-E (1-3) were tested for acetylcholine esterase (AChE) inhibitory activity. However, none of them showed obvious activity.
Experimental Section
General Experimental Procedures. Melting points were obtained on an X-4 micro melting point apparatus. Optical rotations were measured on a JASCO-20C digital polarimeter. UV spectra were recorded using a Shimadzu UV-2401A spectrophotometer. IR spectra were obtained on a Tensor 27 spectrometer with KBr pellets. 1D and 2D NMR spectra were performed on Bruker AM-400, DRX-500, or AVANCE III-600 spectrometers with TMS as an internal standard. Mass spectra were taken on VG Auto Spec-3000 or API-QstarPulsar instruments. X-ray diffraction was performed on a Bruker APEX DUO diffractometer using graphitemonochromated Mo Kα radiation. Column chromatography (CC) was Extraction and Isolation. Air-dried and pulverised plants of L. obscurum were extracted three times with methanol under reflux at 50 °C and the combined extract was removed under vacuum to afford a viscous residue. The crude extract was adjusted at pH 2 with 10% hydrochloric acid and then partitioned twice with acetic ether. Water-soluble materials, which were adjusted at pH 10 with saturated NaOH, were extracted three times with chloroform. The chloroform-soluble materials (479 g) were chromatographed over silica gel CC (32 × 120 cm) eluting with a gradient mobile phase (petroleum ether-acetone 9:1, 8:2, 7:3, 6:4, then methanol) to give 3 major fractions, Fr.A-Fr.C. Fr.A (29 g) was chromatographed on a reversed-phase preparative MPLC (MCI, 70 × 460 mm) column using step-gradient elution with a mixture of methanol/water (v/v, 70% to 100% methanol) to give three subfractions, Fr.A1-Fr.A3. Fr.A1 (13 g) was separated by repeat silica gel CC (4.6 × 50 cm) and recrystalization to offer 1 (230 mg) as well as anhydrolycodoline (2.1 g). Fr.B (159 g) was subjected to a reversed-phase preparative MPLC (MCI, 70 × 460 mm) column with a mixture solvent of methanol/water (v/v, 40% to 100% methanol) to yield five subfractions. Fr.B3 (41 g) was eluted on silica gel CC (6.0 × 60 cm) with acetic ether-acetone (92:8) to yield a large number of lycopodine (30 g), obscurumine B (5.4 g), (+)-acetylfawcettiine (49 mg) and obscurinine (21 mg). Fr.B4 (1.2 g) was purified by repeat silica gel CC (2.6 × 40 cm) to afford 2 (46 mg). Fr.C (136 g) was subjected to gradient elution on a reversed-phase preparative MPLC (MCI, 70 × 460 mm) column using a mixture solvent of methanol/water (v/v, 10% to 80% methanol) to yield three subfractions, Fr.C1-Fr.C3. Fr.C3 (4.2 g) was eluted with chloroform-methanol (4:1) on silica gel CC (3.0 × 40 cm) to yield N-demethyl-β-obscurine (890 mg). Fr.C2 (8.6 g) was separated on silica gel CC (4.0 × 40 cm) using petroleum ether-aceticether-diethylamine (10:1:1) to give acetyldihydrolycopodine (173 mg), lycoflexine (286 mg) and another fraction which was eluted with chloroform-methanol (2:3) to yield 3 (36 mg) and N-demethyl-α-obscurine (938 mg). Acetylcholinesterase Inhibition. Acetylcholinesterase (AChE) inhibitory activity of the compounds isolated was assayed by the spectrophotometric method developed by Ellman et. al. with slightly modification. 21 S-Acetylthiocholine iodide, S-butyrylthiocholine iodide,5,5′-dithio-bis-(2-nitrobenzoic) acid (DTNB, Ellman's reagent), acetylcholinesterase derived from human erythrocytes were purchased from Sigma Chemical. Compounds were dissolved in DMSO. The reaction mixture (totally 200 μL) containing phosphate buffer (pH 8.0), test compound (50 μM), and acetyl cholinesterase (0.02 U/mL), was incubated for 20 min (30 °C). Then, the reaction was initiated by the addition of 40 μL of solution containing DTNB (0.625 mM) and acetylthiocholine iodide (0.625 mM) for AChE inhibitory activity assay, respectively. The hydrolysis of acetylthiocholine was monitored at 405 nm every 30 seconds for one hour. Tacrine was used as positive control with final concentration of 0.333 μM. All the reactions were performed in triplicate. The percentage inhibition was calculated as follows: % inhibition = (E -S)/E × 100 (E is the activity of the enzyme without test compound and S is the activity of enzyme with test compound).
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